Clinical Trial Update: A Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of Allogeneic iNKT Cell Infusion in Subjects With Advanced Pancreatic Cancer [NA]

View source ↗

Summary

This trial is evaluating the safety, tolerability, and preliminary efficacy of an allogeneic iNKT cell infusion in subjects with advanced pancreatic cancer. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Allogeneic iNKT cell infusion

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Pancreatic Cancer | NA | Status: NOT_YET_RECRUITING